EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Epidemiological mapping of drug-susceptible and resistant tuberculosis in 30 WHO high-burden countries: Three decades of GBD 2023 trends, projections to 2043 and concordance with WHO estimates

Azfar A Ishaqui iD, Salman A Ahmad iD, Shoaib Alam, Narendar Kumar, Javeria Farooq, Khalid Orayj, Rabbiya Ahmad, Mohammed Zawiah, Mustapha Mohammed, Muhammad Imran, Asaad A Asaad Khalil, Mohammed A Kaddoura und 3 weitere

Saudi Medical Journal · 2026

DOI: 10.15537/1658-3175.1070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Saudi Medical Journal, 2026. Verfasst von Azfar A Ishaqui und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha 61421, Saudi Arabia. Hauptthemen laut MEDLINE: Tuberculosis, Multidrug-Resistant, Tuberculosis. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Tuberculosis (TB) continues to drive infectious mortality worldwide. The study characterized the evolution of drug-susceptible TB (DS-TB), multidrug-resistant TB (MDR-TB), and extensively drug-resistant TB (XDR-TB) in 30 WHO high-burden countries, linking current patterns to long-term trends, age structure, and forward-looking scenarios to 2043.

Methods

Using GBD 2023 estimates for 1990–2023, we extracted incidence, mortality, and DALYs as age-standardized rates (ASR) per 100,000 with 95% uncertainty intervals. Temporal dynamics were summarized with Estimated Annual Percent Change (EAPC) and extended linearly to 2043. GBD incidence and mortality were compared against WHO national TB series for 2010–2023.

Results

Overall TB incidence ASR declined in 28/30 countries between 1990 and 2023, ranging from a 79.2% reduction in Bangladesh to a 24.9% increase in the Philippines. Mortality and DALY ASR decreased in 29/30 countries. DS-TB incidence dropped in 28/30 settings, while MDR-TB incidence rose in 28/30, from -62.5% in China to +23,603% in Kyrgyzstan. The MDR/RR-TB burden shifted toward older adults (≥ 55 years) in countries such as China (+22 percentage points), whereas youth contributions remained high in Nigeria (∼40%). Projections assuming constant EAPC suggest continued DS-TB declines but sustained MDR-TB in Eastern Europe and Central Asia.

Conclusion

The MDR-TB remains concentrated and often increasing with limited detectable XDR-TB. Age-tailored interventions, universal drug-susceptibility testing, scale-up of all-oral second-line regimens, and adherence support are critical to reverse resistant-TB trajectories while preserving gains against DS-TB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberculosis, Multidrug-ResistantTuberculosisHumansIncidenceWorld Health OrganizationExtensively Drug-Resistant TuberculosisGlobal HealthAntitubercular AgentsDisability-Adjusted Life Years

Stichwörter der Autor:innen

Central AsiaEastern EuropeGlobal Burden of DiseaseTuberculosisdeveloping countriesdrug-resistant tuberculosis

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha 61421, Saudi Arabia.
  • Faculty of Pharmacy, Iqra University, Karachi 75500, Pakistan.
  • Department of Pharmacology, Faculty of Pharmacy & Pharmaceutical Sciences, University of Karachi, Karachi 75270, Pakistan.
  • Department of Pharmacy Practice, Faculty of Pharmacy, University of Sindh, Jamshoro 76080, Pakistan.
  • Department of Pharmacognosy, Faculty of Pharmacy & Pharmaceutical Sciences, University of Karachi, Karachi 75270, Pakistan.
  • Department of Pharmacy, University of Lahore, Lahore 54000, Pakistan.

ORCID-Profile: Azfar A Ishaqui, Salman A Ahmad

Zitieren

APA

Ishaqui, A. A., Ahmad, S. A., Alam, S., Kumar, N., Farooq, J., Orayj, K., Ahmad, R., Zawiah, M., Mohammed, M., Imran, M., Khalil, A. A. A., Kaddoura, M. A., Alshahrani, S. M., Iqbal, A., & Maqsood, M. B. (2026). Epidemiological mapping of drug-susceptible and resistant tuberculosis in 30 WHO high-burden countries: Three decades of GBD 2023 trends, projections to 2043 and concordance with WHO estimates. Saudi Medical Journal. https://doi.org/10.15537/1658-3175.1070

Vancouver

Ishaqui AA, Ahmad SA, Alam S, Kumar N, Farooq J, Orayj K, et al. Epidemiological mapping of drug-susceptible and resistant tuberculosis in 30 WHO high-burden countries: Three decades of GBD 2023 trends, projections to 2043 and concordance with WHO estimates. Saudi Medical Journal. 2026. doi:10.15537/1658-3175.1070

BibTeX
@article{Ishaqui2026,
  author = {Ishaqui, Azfar A and Ahmad, Salman A and Alam, Shoaib and Kumar, Narendar and Farooq, Javeria and Orayj, Khalid and Ahmad, Rabbiya and Zawiah, Mohammed and Mohammed, Mustapha and Imran, Muhammad and Khalil, Asaad A Asaad and Kaddoura, Mohammed A and Alshahrani, Sultan M and Iqbal, Adnan and Maqsood, Muhammad B},
  title = {Epidemiological mapping of drug-susceptible and resistant tuberculosis in 30 WHO high-burden countries: Three decades of GBD 2023 trends, projections to 2043 and concordance with WHO estimates},
  journal = {Saudi Medical Journal},
  year = {2026},
  doi = {10.15537/1658-3175.1070}
}
Kostenlos starten →